Beida Pharmaceutical: It is expected that the net profit will decrease by 33.33%-47.82% in 2025 compared to the previous year.

Beida Medical announced that it is expected to have a net profit of 72-92 million yuan in 2025, a year-on-year decrease of 33.33%-47.82%. The medical distribution sector of the company has seen a decrease in revenue and net profit year-on-year due to the termination of business cooperation between its wholly-owned subsidiary, Beijing Xinyoushi Pharmaceutical Commercial Co., Ltd., and Peking University International Hospital in May 2025. The pharmaceutical industry sector is expected to have a decrease in total profit amount for the reporting period by 39-45 million yuan due to the impact of personnel disposal expenses caused by judicial arbitration.